A new blood-thinning drug Pradaxa is now available for patients at risk of blood clots after surgery. It is available as a daily tablet and does not require constant monitoring as other drugs currently used to prevent venous thromboembolism in patients who have hip and knee replacement surgery, reported The Telegraph.
The thrombosis charity, Lifeblood, wants all hospitals to improve their risk assessments for blood clots in patients when they are first admitted to reduce the unnecessary deaths from the condition. Wider use of this new drug to stop blood clots could save thousands of lives a year.
See also previous post "Blood clot prevenetion lacking in hospital" on 4 February 2008.
No comments:
Post a Comment